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1014-151 Reiiabiiity of Noninvasive Cardiac Output Measurement 
by Whole-Body Electrical Bioimpedence: Comparison 
to Thermodiiution in Diverse Clinical Settings 
mConer. Alex Tsoglin, Yaron Moshkovitz. Edo K&ski, Ahmed Salah. Zvi Vered, 
Daniel Goor, Assaf-Harofeh Medical Center. Zerifin, Israel, NI Medical LTD. Nafania, 
Israel. 
Non-invasive measurement of cardiac output (CO) is a promising alternative to thennodi- 
lution. The NlCaS 2061 system is an innovative device for measuring continuous non- 
invasive CO based on whole-body electrical bioimpendence and analysis of impulse with 
a novel semi-empirical formula correcting for age. sex and body composition. The pur- 
pose of the study was to determine its reliability in diverse medical settings. 
Methods: One hundred and fifty patients (with acute congestive heart failure (CHF) - 29, 
during and after coronary bypass surgery(CABG)dl, during coronary catheterization- 
40) underwent overall 542 simultaneous paired, independent measurements of cardiac 
output (CO) by NlCaS 2001 (NiCAS-CO) and thermodilution (Th-CO). 
&6gf& We have found good agreement between NiCAS-CO and Th-CO: Linear regres- 
sion is r=0.91(pc0.05). Bias (mean between-method difference) is -0.03 Umin. and praci- 
sion (bias +/- 2SD) is -1.45 to +1.37 L./min. This correlation is maintained throughout the 
different clinical settings and in a wide range of CO measurements (Figure). The correla- 
tion is rxO.66 in patients with acute CHF, 0.94 during coronary catheterizations and 0.9 
during and after CABG. 
Conclusions:For cardiac and cardiac surgery patients, NiCAS-CO measurement using 
whole-body bioimpendence is accurate. This may have important application for non- 
invasive on-line monitoring and treatment for such patients. 
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1014-153 Accuracy and Reproducibility of Nonlnvasively 
Determined Left Ventricular End Diastolic Pressure in 
the Catheterization Laboratory and the Dffice Setting 
Ram G. m, Patricia A. Woods, Costas T. Lambrew, Claire M. Berg, Daniel A. 
Pietro, Thomas P. Rocco. Frederick W. Welt, Frederick W. Welt, Peter Sacchetti, Kevin 
M. McIntyre. VA Healthcare System and Harvard Medical School, Boston, 
Massachusetts, Maine Medical Center, Portland, Maine. 
Background: We have previously reported that VerfCor,” a noninvasive system that 
analyzes the arterial pressure decline during a Valsalva maneuver, can be used to mea- 
sure left ventricular end diastolic pressure (LVEDP). 
Methods: In order to assess the accuracy and reproducibility of the results we tested 
VeriCor in the catheterization laboratory in patients during elective left heart catheteriza- 
tion and in the office setting in cardiac patients during outpatient evaluations. Paired 
LVEDP measurements by invasive left heart catheterization and VeriCor methods were 
obtained in the catheterization laboratory (N=20) and by VeriCor in the office-setting 
(N=76) by sequential testing (Tests 1 and 2). 
Results: Results show that VerfCor measurements of LVEDP in the catheterization lab 
correlate well (r = 0.90) with catheter measured LVEDP and that sequential VeriCor tests 
in the office-setting correlate well with each other (r = 0.60) 
Concluslan: VeriCor can accurately and reproducibly measure LVEDP and can be used 
in the office setting for management of cardiac patients. 
1014-154 Ventricular interaction impacts Left Ventricular Systolic 
Function in Heart Failure 
vHorne, Richard Townfey, Colleen Keoughan, Ahmad AbdeCWahed, Gerhard 
Stroink, Dalhousie University. Halifax, Canada. 
BACKGROUND. In the normal heart, ventricular interaction can impact left ventricular (LV) 
systolic function, but its effect in hearl failure is unclear. 
METHODS. We used echocardiography during lower body negative pressure (LBNP) (-15 
mmHg) to study ventricular interaction in 20 heart failure patients (efection fraction c.40 
prior to beta blocker therapy). 01 these, 25% had restrictive filling (REST)(deceleratfon time 
cl40 ms). 
RESULTS. Comparing REST to non REST patients, there was no significant difference in 
mean ejection fraction or LV size. With LBNP, there was no significant change in LV end- 
diastolic volume for either group. Both REST and non REST patients showed no difference 
in LV free wall systolic function (change in shortening 10 mid free wall chords) (see figure). 
Septal diastolic loading (end-diastolic chord length) tended to decrease in REST (sum 10 
chords, 36.6 to 35.7 cm), and increase in non REST (35.9 to 36.9 cm), p=.O6. Changes in 
septal systolic motion ware also opposite, with systolic shortening decreasing in REST 
(sum 10 chords 7.2 to 5.7 cm), and increasing in non REST (6.0 to 6.6 cm), (p<.OO4). LV 
ejection fraction was impacted by altered septal mechanics. The change in ejection fraction 
with LBNP was -7 points in REST, but only -2 points in non REST (pe.05). 
CONCLUSION. In heart failure, restrictive filling predicts altered septal mechanics. This 
ventricular interaction is associated with a drop in LV ejection fraction with decreased cen- 
tral volume. 
1014-152 Reliability of Noninvasive Cardiac Output Measurement 
by Whole-Body Electrical Bioimpadence in Patients 
Treated for Acute Congestive Heart Failures 
S&Cc&r, Alex Tsoglin, Edo Kaluski, Yron Moshkovitz, Ahmed Salah, Olga Milovanov, 
Ricardo Krakover, Zvi Vered, Daniel Goor, Assaf-Harofeh Medical Center, Zerifin, Israel, 
N/ Medical LJD, Natania, Israel. 
The NlCaS 2001system is a new device for non-mvasive, continuous measurement of 
cardiac output (CO) based on whole-body electrical bioimpendence and analysis of 
impulse with a novel semi-empirical formula correcting for age, sex and body composi- 
tion. We evaluated its reliability in monttorlng patients with acute congestive hearl failure 
(CHF). 
M&gd& Thirty patients submitted for invasive hemodynamic monitoring with Swan- 
Ganz catheters due to acute CHF where enrolled in this study. CO was measure repeat- 
edly, simultaneously and independently by NlCaS 2001 (NiCAS-CO) and thermodilution 
(Th-CO). For each patient we obtained 3-4 measurements while under stable medical 
treatment. In 12 patients we also obtained 4 measurements par patient, while treatment 
with IV vasodilators (Isosorbidedinitrate. ISDN) was initiated. 
&&t&z Out of 30 patients, 10 where monitored while mechanically ventilated and 2 
while treated by IABP. We have found good agreement between NiCAS-CO and Th-CO: 
Linear regression is r=O.86 (p<O.O5). Bias (mean between-method difference) is -0.05 U 
min. and precision (bias +I- 2SD) is -1.35 to +1.27 L.lmin. In the subgroup of patients 
monitored while treated with IV ISDN, The NlCaS 2001 system correctly detected the CO 
increase induced by ISDN (R=0.95, PcO.05, Figure). 
Conclusions: NlCaS 2001 is reliable for monitoring CO in patients admkted due to acute 
CHF. 
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